0000000000444966

AUTHOR

Antonella Carollo

showing 3 related works from this author

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

2011

Abstract Abstract 5302 Background: A multicentre randomized controlled trial (RCT) was designed to assess the effectiveness of long-term sequential deferiprone-deferoxamine (DFO-DFP) versus DFP alone to treat thalassaemia major (TM) (Maggio et al.,2009). Effectviness, survival, adverse events and costs were comparable between the groups. These findings were confirmed in a further 21-month follow-up (Pantalone et al., 2011). Moreover, deferiprone-alone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular ejection function (LVEF). However, little is known of its relative effect on LVEF after long-term treatment. Therefore, data f…

medicine.medical_specialtyEjection fractionbusiness.industryThalassemiaImmunologyDeferasiroxRetrospective cohort studyCell BiologyHematologymedicine.diseaseBiochemistrylaw.inventionchemistry.chemical_compoundchemistryRandomized controlled triallawHeart failureInternal medicinemedicineCardiologybusinessDeferiproneSurvival analysismedicine.drugBlood
researchProduct

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure …

2011

Abstract Abstract 3197 Background: The prognosis for thalassemia major (TM) has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop secondary iron overloading, and eventually death, particularly from cardiac disease. The possibility of detecting easily and earliest the patients at risk of cardiac death is so far the main challenge of clinical management of these patients. Therefore, the mean reduction of Left Ventricular Ejection Fraction (LVEF), determined by echocardiography, was evaluated over the time. Methods: Among the 413 observed patients only 188 had complete records for LVEF measurements during, at least, five considered …

medicine.medical_specialtyeducation.field_of_studyEjection fractionmedicine.diagnostic_testbusiness.industryImmunologyPopulationMagnetic resonance imagingCell BiologyHematologymedicine.diseaseLogistic regressionBiochemistryGeeSurgeryInternal medicineHeart failureLinear regressionCardiologyMedicinebusinesseducationGeneralized estimating equation
researchProduct

A Particular Focus on the Prevalence of α- and β-Thalassemia in Western Sicilian Population from Trapani Province in the COVID-19 Era

2023

Thalassemia is a Mendelian inherited blood disease caused by α- and β-globin gene mutations, known as one of the major health problems of Mediterranean populations. Here, we examined the distribution of α- and β-globin gene defects in the Trapani province population. A total of 2,401 individuals from Trapani province were enrolled from January 2007 to December 2021, and routine methodologies were used for detecting the α- and β-globin genic variants. Appropriate analysis was also performed. Eight mutations in the α globin gene showed the highest frequency in the sample studied; three of these genetic variants represented the 94% of the total α-th…

thalassemiagenotypeOrganic Chemistryphenotype in the diagnosisGeneral MedicineTrapani population<i>α-</i> and <i>β-globin</i> genes defectsCatalysisComputer Science ApplicationsInorganic ChemistryPhysical and Theoretical ChemistryMolecular Biologyα- and β-globin genes defectSpectroscopyphenotype in the diagnosi
researchProduct